Conversion to a Belatacept Based Immunosuppression Regimen in Renal Transplant Recipients

被引：0
|
作者：
Paplaczyk, K. [1 ]
Cunningham, K. [1 ]
D'Agostino, C. [1 ]
Pinelli, D. [1 ]
Schulte, J. [1 ]
Shetty, A. [1 ]
机构：
[1] Northwestern Mem Hosp, Chicago, IL 60611 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2020年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
116
引用
收藏
页码：439 / 440
页数：2
相关论文
共 50 条
  • [41] Belatacept-Based Immunosuppression in Heart Transplant Recipients: A Single-Center Experience
    Magua, W.
    Okoh, A. K.
    Karadkhele, G. M.
    Galani, J.
    Gill, D.
    Gupta, D.
    Vega, J. D.
    Larsen, C. P.
    Morris, A. A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S886 - S886
  • [42] Infections in Kidney Transplant Recipients on Belatacept versus Tacrolimus-Based Immunosuppression.
    Gattis, S.
    Basu, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 933 - 934
  • [43] Belatacept Conversion in Proteinuric Renal Transplant Recipients: An Interventional Multi-Center Trial
    Efe, O.
    Al Jurdi, A.
    Wojciechowski, D.
    Safa, K.
    Gilligan, H.
    Chandraker, A.
    Azzi, J.
    Weins, A.
    Riella, L. V.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 739 - 740
  • [44] Tacrolimus to belatacept conversion in proteinuric kidney transplant recipients
    Efe, Orhan
    Al Jurdi, Ayman
    Eiting, Morgan Mabey
    Marks, Christine Rogers
    Cote, Mariesa Ann
    Wojciechowski, David
    Safa, Kassem
    Gilligan, Hannah
    Azzi, Jamil
    Goyal, Nitender
    Raynaud, Marc
    Loupy, Alexandre
    Weins, Astrid
    Riella, Leonardo V.
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [45] Belatacept Conversion in Kidney Transplant Recipients for Prolonged DGF
    Wojciechowski, D.
    Chandran, S.
    Vincenti, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 456 - 456
  • [46] Belatacept Conversion in Kidney Transplant Recipients for Prolonged DGF
    Wojciechowski, D.
    Chandran, S.
    Vincenti, F.
    TRANSPLANTATION, 2014, 98 : 456 - 456
  • [47] Toxicity Driven Conversion to Belatacept in Kidney Transplant Recipients
    Cohen, E.
    Asch, W.
    Formica, R.
    Tichy, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [48] Belatacept Conversion Protocols and Outcomes in Kidney Transplant Recipients
    Yazdi, Mona
    Kahwaji, Joseph M.
    Meguerditchian, Sam
    Lee, Roland
    TRANSPLANTATION PROCEEDINGS, 2021, 53 (03) : 976 - 983
  • [49] DOSING RATIONALE OF BELATACEPT IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS SWITCHING FROM CALCINEURIN INHIBITOR-BASED REGIMEN.
    Lee, S.
    Zhou, Z.
    Roy, A.
    Jones-Burton, C.
    Harler, M.
    Shen, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S75 - S75
  • [50] Clinical Outcomes of Conversion from Calcineurin Inhibitor to Belatacept-Based Immunosuppression in Highly Sensitized Kidney Transplant Recipients.
    Sethi, S.
    Choi, J.
    Vo, A.
    Peng, A.
    Lim, K.
    Najjar, R.
    Jordan, S.
    Huang, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 291 - 292
12345